Associate Professor, Consultant Hematologist
University Hospital of Cologne
Cologne, Germany
Barbara Eichhorst graduated at the Medical school of the University of Munich and wrote her doctoral thesis in the field of hemataology evaluating signalling transduction pathways in Hodgkin cells. Dr Eichhorst finished her internship at the department III for internal medicine of the University of Munich and specialized in internal medicine. Since February 2005 she works at the Department I for Internal Medicine and Center for Integrated Oncolgy Aachen, Bonn, Cologne, Duesseldorf at the University hospital of Cologne and finished her specialisation in hematology and internal oncology. She is assistant professor and consultant since December 2012 and adjunct professor of the University of Cologne since July 2019.
Her main focus of interest is chronic lymphocytic leukemia (CLL). As leading group member of the German CLL Study Group (GCLLSG) she was and is principal investigator in several phase II and III trials evaluating treatment optimization in CLL. Since 2005 she is secretary of the GCLLSG (head Prof. Dr. Michael Hallek) and since 2022 deputy chair. Dr. Eichhorst published many papers in the field of prognostication and treatment of CLL as well as Richter transformation including national and international guidelines. She is also a member of several national and international organizations including the European Haematology association and American Society of Hematology and was elected as member of International Workshop of CLL (iwCLL) in 2019.
Multiparty "Statement of Perspective"
Saturday, October 7, 2023
4:00 PM – 4:35 PM EDT
Sunday, October 8, 2023
9:15 AM – 9:25 AM EDT
Sunday, October 8, 2023
3:05 PM – 3:10 PM EDT
Monday, October 9, 2023
11:15 AM – 11:25 AM EDT